semaxinib and Pulmonary-Disease--Chronic-Obstructive

semaxinib has been researched along with Pulmonary-Disease--Chronic-Obstructive* in 1 studies

Other Studies

1 other study(ies) available for semaxinib and Pulmonary-Disease--Chronic-Obstructive

Article	Year
Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema. American journal of respiratory and critical care medicine, 2020, 10-01, Volume: 202, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; Deferoxamine; Disease Models, Animal; Endothelial Cells; Hepatocyte Growth Factor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Iron Chelating Agents; Lung; Mice; Mice, Knockout; Microvessels; Pericytes; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrroles; Smoke	2020

Article

Year

Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.

American journal of respiratory and critical care medicine, 2020, 10-01, Volume: 202, Issue:7

Topics: Angiogenesis Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; Deferoxamine; Disease Models, Animal; Endothelial Cells; Hepatocyte Growth Factor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Iron Chelating Agents; Lung; Mice; Mice, Knockout; Microvessels; Pericytes; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrroles; Smoke

2020